Cargando…

Which drugs are best for overactive bladder? From patients’ expectations to physicians’ decisions

AIM: In order to help physicians determine which drugs are the best for treating overactive bladder (OAB) symptoms, this review considered three questions: what are the patient's expectations? What information is generated by the Multicriteria Decision Analysis (MCDA) model? What can physicians...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milsom, Ian, Wagg, Adrian, Oelke, Matthias, Chapple, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Non‐systematic Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047881/ https://www.ncbi.nlm.nih.gov/pubmed/33251651 http://dx.doi.org/10.1111/ijcp.13870

Ejemplares similares

Patients’ Preferences and Expectations in Overactive Bladder: A Systematic Review
por: Cicione, Antonio, et al.
Publicado: (2023)

What are the chances of improvement or cure from overactive bladder? A pooled responder analysis of efficacy and treatment emergent adverse events following treatment with fesoterodine
por: Wagg, Adrian S., et al.
Publicado: (2021)

Overactive bladder: strategies to ensure treatment compliance and adherence
por: Dhaliwal, Prabhpreet, et al.
Publicado: (2016)

Mirabegron in the Management of Overactive Bladder Syndrome
por: O’Kane, Miriam, et al.
Publicado: (2022)

The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
por: Ulahannan, Danny, et al.
Publicado: (2009)

Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)
por: Oelke, Matthias, et al.
Publicado: (2015)

Safety and Tolerability of Fesoterodine in Older Adult Patients with Overactive Bladder
por: Heesakkers, John, et al.
Publicado: (2022)

What Are Realistic Expectations to Become Free of Overactive Bladder Symptoms? Experience from Non-interventional Studies with Propiverine
por: Müderrisoglu, A. Elif, et al.
Publicado: (2022)

Does fesoterodine have a role in the treatment of poorly managed patients with overactive bladder?
por: Morris, Vikky, et al.
Publicado: (2014)

Clinical utility of transdermal delivery of oxybutynin gel via a metered-dose pump in the management of overactive bladder
por: Wagg, Adrian
Publicado: (2012)

The Overactive Bladder Symptom Score, International Prostate Symptom Score–Storage Subscore, and Urgency Severity Score in Patients With Overactive Bladder and Hypersensitive Bladder: Which Scoring System is Best?
por: Chuang, Fei-Chi, et al.
Publicado: (2018)

Factors Associated with Decisions for Initial Dosing, Up-Titration of Propiverine and Treatment Outcomes in Overactive Bladder Syndrome Patients in a Non-Interventional Setting
por: Amiri, Marjan, et al.
Publicado: (2021)

The Association Between Overactive Bladder and Falls and Fractures: A Systematic Review
por: Szabo, Shelagh M., et al.
Publicado: (2018)

Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK
por: Nazir, Jameel, et al.
Publicado: (2017)

Treatment Patterns for Patients on Overactive Bladder Therapy: A Retrospective Statistical Analysis Using Canadian Claims Data
por: Wagg, Adrian, et al.
Publicado: (2016)

Do Older Adults with Overactive Bladder Demonstrate Impaired Executive Function Compared to Their Peers Without OAB?
por: Gibson, William, et al.
Publicado: (2020)

Urinary urgency acts as a source of divided attention leading to changes in gait in older adults with overactive bladder
por: Gibson, William, et al.
Publicado: (2021)

Overactive bladder syndrome: Current pathophysiological concepts and therapeutic approaches
por: Osman, Nadir I., et al.
Publicado: (2013)

Non-invasive transcutaneous electrical stimulation in the treatment of overactive bladder
por: Slovak, Martin, et al.
Publicado: (2015)

Solifenacin significantly improves all symptoms of overactive bladder syndrome
por: CHAPPLE, C R, et al.
Publicado: (2006)

On examination by which the best physicians are recognized
por: Nutton, Vivian
Publicado: (1989)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Recurrent Endometrial Cancer: Which Is the Best Treatment? Systematic Review of the Literature
por: Restaino, Stefano, et al.
Publicado: (2022)

Associations among Physician–Patient Communication, Patient Satisfaction, and Clinical Effectiveness of Overactive Bladder Medication: A Survey of Patients with Overactive Bladder
por: Izumi, Naoko, et al.
Publicado: (2022)

Drugs for the overactive bladder: are there differences in persistence and compliance?
por: Andersson, Karl-Erik
Publicado: (2017)

OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder
por: Sievert, K-D, et al.
Publicado: (2014)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

Pooled solifenacin overactive bladder trial data: Creation, validation and analysis of an integrated database
por: Chapple, Christopher R., et al.
Publicado: (2016)

Updating the evidence on drugs to treat overactive bladder: a systematic review
por: Hsu, Frances C., et al.
Publicado: (2019)

Drug therapy of overactive bladder - What is coming next?
por: Andersson, Karl-Erik
Publicado: (2015)

Physician-patient communication about overactive bladder: Results of an observational sociolinguistic study
por: Hahn, Steven R., et al.
Publicado: (2017)

Percutaneous versus Transcutaneous Electrical Stimulation of the Posterior Tibial Nerve in Idiopathic Overactive Bladder Syndrome with Urinary Incontinence in Adults: A Systematic Review
por: Agost-González, Aida, et al.
Publicado: (2021)

Challenging patient phenotypes in the management of anaemia of chronic kidney disease
por: Pramod, Sheena, et al.
Publicado: (2021)

Delivering patient‐centered care through shared decision making in overactive bladder
por: Paudel, Roshan, et al.
Publicado: (2022)

Pharmacologic management of overactive bladder
por: Lam, Sum, et al.
Publicado: (2007)

Medical management of overactive bladder
por: Ubee, Sarvpreet S., et al.
Publicado: (2010)

Overactive bladder in the vulnerable elderly
por: Wolff, Gillian F, et al.
Publicado: (2014)

Urinary biomarkers of overactive bladder
por: Tian, Xiao-Jun, et al.
Publicado: (2019)

Review of the epidemiology of overactive bladder
por: Eapen, Renu S, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q2n0e9abtgv0t9ees560a6j6ns